FDA 483 Observations, Trends, and Expectations
The goal of the FDA is to ensure the safety, efficacy and purity of our products. In this webinar, we can learn what the FDA expects and finds during the inspection process. We will examine FDA 483 Observations for 2016 in the Biologics, Pharmaceuticals and Medical Device industries. We will discuss what trends are evident using an evaluation of the past five years of 483 Observations data. This information can help your organization learn what impact this data can have on our improvement efforts and compliance concerns.
- Discuss current trends 483’s across Biologics, Pharmaceuticals and Medical Device industries
- Review what the FDA is citing in 483’s
- Evaluate each industry 483s
- Identify key patterns
- Examine how this data influences our resources and efforts
DATE: Tuesday JULY 25, 2017
TIME: 10 am PST
PRESENTER: Collis Laton-Floyd
ON DEMAND WEBINARS
PathWise has a library of over 20 quality system presentations of previously recorded webinars for you to view!
Gain access to ALL PathWise webinars for one calendar year!LEARN MORE!
REGISTER NOW TO ATTEND OUR FEATURED WEBINAR!
Attend the live session for FREE!
Session is limited to 100 registrants- don’t miss this opportunity!REGISTER NOW!
** Registration fee is limited to 1 subscriber only. Webinars are not for resale, reproduction or redistribution. Please contact firstname.lastname@example.org if you would like to make a group purchase. All webinar purchases are subject to the terms and conditions of the PathWise Webinar License Agreement.